Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Wearable Electrical Incontinence Device in Subjects: A Non-significant Risk Clinical Evaluation of FemPulse Therapy in Women With OAB

NCT03874637 is registered in ClinicalTrials.gov with FemPulse Corporation as lead sponsor.

NCT NCT03874637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03874637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Wearable Electrical Incontinence Device in Subjects: A Non-significant Risk Clinical Evaluation of FemPulse Therapy in Women With OAB
Lead sponsor
FemPulse Corporation
Phase
Not applicable
Overall status
Completed
Start date
February 14, 2017
Completion date
May 17, 2017
Enrollment
15 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

urinary bladder, overactive